The lightning-fast quest for COVID vaccines — and what it means for other diseases
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
Contaminants found in Pfizer vaccine in cities near Tokyo and Osaka | The Japan Times
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 | Nature Communications
FDA approval of Pfizer's COVID-19 vaccine spurs American confidence: Harris Poll | Fierce Pharma
Frontiers | COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations
Pfizer-biontech Covid-19 Vaccine
Covid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says Pfizer Executive - WSJ
Pfizer CEO confirms coronavirus vaccine trial may have results in October
Moderna Vaccine More Effective Than Pfizer, J&J, Especially After 4 Months: CDC
FDA and CDC Greenlight Pfizer COVID-19 Vaccine for Children Ages 5 to 11 | AHA
Healthcare Providers for 12 years of age and older, purple cap (must dilute) 12222022
Article by cardiologist Aseem Malhotra made unsupported claims about the benefits and risks of COVID-19 vaccination - Health Feedback
Vaccines | Free Full-Text | An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination
Myths and Facts About the Vax — Debunking Common COVID-19 Vaccine Myths > TRICARE Newsroom > Articles
Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August ...
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021 | MMWR
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
